Standout Papers

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results ... 2016 2026 2019 2022 428
  1. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials (2016)
    Jennifer S. Temel, Amy P. Abernethy et al. The Lancet Oncology

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 57 standout
Sub-graph 1 of 21

Citing Papers

Ponsegromab for the Treatment of Cancer Cachexia
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
1 intermediate paper

Works of John Friend being referenced

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
2016 Standout

Author Peers

Author Last Decade Papers Cites
John Friend 755 261 35 215 38 1.3k
Noriaki Takabatake 374 205 46 660 38 1.3k
Ammon Handisurya 272 152 30 81 33 1.3k
James P. Maloney 182 303 147 526 40 1.6k
Maria Paola Garancini 246 299 60 168 23 1.6k
Anne‐Margret Wingen 128 212 10 220 52 1.4k
Nilgün Güvener 184 113 7 86 37 1.0k
Katerina Trajanoska 403 361 62 167 44 1.5k
Damien Ashby 186 61 30 321 48 1.7k
Alexandra Ahmet 231 153 12 213 35 1.4k
Mahmut Gök 122 134 34 144 32 1.3k

All Works

Loading papers...

Rankless by CCL
2026